RYR1 should also be considered in dominant and sporadic congenital myopathy patients without evocative cores or central nuclei on the muscle biopsy, especially if the patient manifests neonatal or infancy-onset hypotonia improving over time. This evidence concerns the gene RYR1 and congenital myopathy.